SUMMARY
Enzymatic debridement (ED) is increasingly used for cutaneous burns. Compared with surgical debridement, ED has better preservation of viable dermis, less blood loss and autografting, however ED is painful. Current recommendations suggest local anaesthesia (LA) is useful for minor burns, but the evidence base is minimal. In our centre, we routinely use LA with good analgesic effect. This study was a single-centre, prospective analysis conducted at the Queen Victoria Hospital (UK). Patients had at least superficial partial thickness burns and received subcutaneous LA prior to ED during a 1-year period (October 2019-September 2020). Pain was assessed using a numeric scale of 1-10, recorded before, during and after the procedure. In total, 27 patients were included (n=17 males) with a median age of 47 (18-88 years). The mean total burn surface area was 1.5% (0.3-5.0). Treated sites included head and neck (1), trunk (5), upper limb (9) and lower limb (16). The most used LAwas bupivacaine 0.25% (n=25), followed by lidocaine 1% (n=2). Some required additional oral analgesia (n=8) or a regional blockade (n=2). Average pain score during debridement was 1.9 We have found LA effective, with favourable pain scores in comparison to previous studies with oral analgesia or regional blockade. LA is quick and easy to perform, as opposed to nerve blocks, which require trained personnel with ultrasound guidance. LA is a useful analgesic for patients with minor cutaneous burns undergoing ED. In some cases, it is sufficient without additional oral analgesia or regional blockade.
Keywords: enzymatic debridement, NexoBrid, local anaesthesia, burns
RÉSUMÉ
Le débridement enzymatique (DE) des brûlures est de plus en plus utilisé, ayant l’avantage d’être moins hémorragique et plus respectueux des tissus sains que la chirurgie, au prix d’une douleur plus importante. Les recommandations actuelles suggèrent l’utilisation de l’anesthésie locale (AL) sur les petites zones, avec un niveau de preuve minime. Dans notre centre, nous utilisons régulièrement l’AL, avec un bon effet analgésique. Cette étude a été conduite dans le CTB de l’hôpital Queen Vicoria (Royaume Uni). Durant 1 année (octobre 2019- septembre 2020), les patients devant bénéficier d’un DE recevaient préalablement une AL par infiltration. La douleur a été évaluée par échelle numérique (0 à 10) avant, pendant et après la procédure. Nous avons étudié 27 patients dont 17 hommes, d’âge médian 47 ans (18 à 88), brûlés en moyenne sur 1,5% (0,3 à 5), sur le cou (1), le tronc (5), le membre supérieur (9) et le membre supérieur (16). La bupivacaïne 0,25% a été la plus utilisée (25 fois), la lidocaïne 1% l’étant anecdotiquement (2 fois). Une analgésie complémentaire a été 10 fois nécessaire : orale 8 fois, régionale 2 fois. La douleur procédurale était cotée à 1,9 en moyenne. Nous estimons que l’AL est efficace, avec des scores de douleur favorables comparativement aux analgésies orale ou régionale. À la différence des analgésies régionales qui nécessitent un personnel entraîné et un écho- guidage, l’AL est facile et rapide. Elle peut être suffisante à elle seule pour le DE de brûlures minimes.
Mots-clés: débridement enzymatique, Nexobrid®, anesthésie locale, brûlure
Introduction
Within the last decade, enzymatic debridement (ED) has become an increasingly prevalent method in treating mid to full thickness burns, particularly with mixed depth patterns. NexoBrid, a bromelainbased collagenase derived from the stems of pineapples, selectively removes the necrotic tissue, whilst preserving the viable dermis beneath.1 Numerous studies have proven the efficacy of ED2-5 and it is considered a safe alternative to surgical debridement, the current standard of care (SOC). Advantages of ED over the SOC include reduced blood loss, incidence of burn wound infection, and necessity for autografting.1,3 Additionally, ED results in shorter length of hospital stay and cheaper costs in comparison to the SOC.6 However, ED is still a painful procedure,7,8 with the magnitude of pain experienced influenced by the afflicted anatomical site, the total burn surface area (TBSA), its depth, and the presence of any concomitant injuries or other conditions.9
Pain management is vital in burn care. However discrepancies between practice standards for treatment of burn pain have long been noted.10,11 Inadequate analgesia can lead to an increased perception of pain, poor compliance to rehabilitation therapies, and a loss of faith in the burns team.12 Poor experience with acute burn pain increases the incidence of chronic pain, depression and suicidal ideation.13,14
During ED, sufficient analgesia is required at least 15 minutes before application, throughout the 4-hour procedure and upon removal of the Nexo-Brid. Due to the intricacies of the pain experienced, an interdisciplinary approach is recommended.15 According to the European Consensus Guidelines, it is preferable to use analgosedation over general anaesthetic.8,16 Local anaesthesia has been suggested as being useful for minor burn wounds treated by ED, however the evidence-base for its use is minimal. In our centre, we frequently use LA with good analgesic effect. The purpose of our analysis was to evaluate the safety of LA and understand if it is a reliable option for ED. Here we describe our experience of routine use of subcutaneous LA injections for ED and assess its analgesic outcomes using a prospectively maintained database.
Materials and methods
Study design
This was a single-centre, prospective collected analysis of patients treated with ED at the Queen Victoria Hospital in East Grinstead, UK. The data covered a 1-year period, between October 2019 to September 2020 as this coincided with a change in our data collection that allowed more detailed analysis.
Study population
Twenty-seven consecutive patients, 17 male and 10 female, were identified from our database. All patients had to have a partial thickness, deep dermal or full thickness burn treated with ED and to have had LA as the primary form of anaesthesia/analgesia.
Standard protocol for LA in ED
The patients received cutaneous LA prior to undergoing ED. We assessed their perceived pain using a standardised numeric scale before, during and after the procedure. The patient would describe their comfort level from 1 to 10, with 1 = no pain and 10 = the worst pain possible. We also recorded whether additional rescue analgesia, either with oral medication or regional anaesthesia, was necessary.
Data analysis
Data was collected and entered into Microsoft Excel (2013, Microsoft, USA), and data analysis was performed upon it using this software. All data was checked for accuracy and completeness prior to statistical analysis.
Results
In total, 27 consecutive patients were included (n=17 males) with a median age of 47 (range 18-88 years) (Table I). The mean TBSAwas 1.5% (0.3-5.0). Five patients had a partial thickness burn, 13 had a deep dermal burn and the remaining 9 had a full thickness burn. Treated sites included the head and neck (1), trunk (5), upper limb (9) and the lower limb (16). ED was performed a median of 3 days post-injury, with a range of 1-4. The most commonly used LA was bupivacaine 0.25% with adrenaline (n=25), followed by lidocaine 1% with adrenaline (n=2). Doses of bupivacaine ranged from 0-120 ml, whereas for lidocaine both patients received 30ml. None of the patients reached the maximum safe dose of LA. Eight patients required additional oral analgesia, receiving between 5-20mg morphine or an alternative medication. Two patients required an additional regional block, one received a right lower limb block, and the other a femoral and popliteal block.
Table I.
Patient characteristics
| Median | Minimum | Maximum | |
|---|---|---|---|
| Age | 47 | 18 | 88 |
| Days post-burn | 3 | 1 | 4 |
| Mean | Minimum | Maximum | |
| %TBSA | 1.5 | 0.3 | 5 |
| Burn site | Head/neck = 1 | Trunk = 5 | Upper limb = 9 Lower limb = 16 |
| Burn depth | Partial thickness = 5 | Deep dermal = 13 | Full thickness burn = 9 |
The average pain score prior to ED was 2.1 (Table II). During the procedure it decreased to 1.9 and then after ED had been completed to a further 1.4. Separating the 9 patients with burns to the upper limbs, the average pain score before ED procedure was also 2.1, during the procedure it was 1.7, and after ED it decreased to 0.1. A single patient had a high pain score increasing the average, but his pain score was very high before the procedure as well.
Table II.
Results
| LA | Bupivacaine 0.25% = 25 | Lidocaine 0.1% = 2 | |
|---|---|---|---|
| Additional analgesia | Oral = 8 | Block = 2 | |
| Average pain score (1-10) | Before = 2.1 | During = 1.9 | After = 1.4 |
| Average pain score (1-10) upper limb | Before = 2.1 | During = 1.7 | After = 0.1 |
Discussion
This cohort study evaluating LA for ED is one of the largest in the published literature. Our practice at QVH has evolved to routinely use LA for minor burn wounds. We have found LA highly effective, with favourable pain scores in comparison to previous studies using oral analgesia or regional blockade. Most patients with an upper extremity burn (n=7/9) received adequate analgesia with LA, without the need for regional blockade, which is the recommended modality for burn wounds at this site.
In the initial European Consensus Guidelines,8 only 1 of the 10 centres had experience with ED under LA, however they had reported significant and prolonged pain after this procedure. In the updated guidelines, 4 out of 12 of the participating centres had used LA, however there was still paucity in the literature regarding its use during ED.16
Thermal burn wounds can cause significant pain. Partial thickness burns elicit pain due to the tissue damage exposing nerve endings, whereas full thickness burns can be insensate due to the loss of the underlying nociceptors. However, this is not always the case, as deep burns may have areas of shallower burn injury, where the nerve endings may not have been completely destroyed.17 Another issue faced by burn wounds, is that the pain does not stop after injury, but can be exacerbated by frequent dressing changes, physiotherapy, and other interventions. Procedural burn pain is challenging to manage, due to its variability and intensity.18 NexoBrid evokes procedural pain,4 to the extent that it has been theorised that pain is limiting its wider utilisation.19 The pain is attributable to the activation of myelinated A-delta fibres, which produce an initial extremely sharp pain, and unmyelinated C fibres, which prolong the pain further.20
Previous studies have shown regional anaesthesia to be a good modality for managing pain during ED.2,8 This is also comparable to other procedures besides ED. Shank et al. demonstrated lower pain scores using regional anaesthesia than with just LA infiltration alone during paediatric reconstructive burn surgery.21 This was cited as being most likely attributed to greater precision of administration of the anaesthetic due to the use of ultrasound guidance. However, regional anaesthesia, although it does alleviate the necessity to undergo the procedure in the operation theatre, must still be performed by an anaesthetist or a doctor with specific training including use of ultrasound. It also is dependent upon knowledge of the local anatomy, due to the potential risk of neurovascular injury from trauma due to the block needle.22 The randomised control trial by Tarsia et al. for the treatment of facial lacerations found that regional anaesthesia was more painful to administer, with a greater chance of failure, resulting in rescue LA, than just infiltration with LA alone.23
LA is cheaper than both regional and general anaesthesia. This is attributable to the decreased duration of hospital stay, equipment requirement, and utilisation of the operating theatre.24 Direct infiltration with LA is also hypothesised to have a positive effect on wound healing, due to its antimicrobial and anti-inflammatory properties, influence on wound pH and scar formation.25-27 The increased risk of infection should also be considered with the application of regional anaesthesia, as burn patients have some of the highest rates of nosocomial infections, due to the prolonged hospitalisation, disruption of the skin barrier and dysregulation of the immune response.28 Placement of peripheral catheters through the skin can lead to catheter-associated infections,29 and epidural anaesthesia can lead to the formation of an epidural abscess, albeit this is a rare occurrence.30
Another point to consider for peripheral nerve blocks of the extremities is the necessity for early mobilisation. Early splinting with mobility and range of motion therapy is highly beneficial to burn wound/graft healing.31,32 Complete motor block under spinal anaesthesia may last up to 120 minutes, however there is great variability of duration.33 If LA could be routinely utilised by other burn centres, this could greatly improve the utilisation, efficacy, and patient experience of ED.
Our study has several limitations that require acknowledgement. Despite being one of the largest studies for LA use in ED in comparison to the rest of the literature, the population size does still limit the statistical analysis that can be performed.
The nature of application of LA and regional anaesthesia does not allow for blinding of neither patients nor practitioners. The pain scoring system used to quantify the pain experience is standardised, however pain is a subjective experience, and is subject to many variables.
In conclusion, LA is a safe approach for the ED of small burns, whether given alone or with additional analgesia. We still recommend following a stepwise pain management approach, and to ensure appropriate rescue analgesia is available if required. All patients undergoing ED should be discussed with anaesthetics, even if LA is the only approach planned for.
BIBLIOGRAPHY
- 1.Rosenberg L: Enzymatic debridement of burn wounds. In: “Total Burn Care”, 131-135.el, W.B. Saunders, 2012. [Google Scholar]
- 2.Schulz A, Perbix W, Shoham Y, Daali S, et al. : Our initial learning curve in the enzymatic debridement of severely burned hands - management and pit falls of initial treatments and our development of a post debridement wound treatment algorithm. Burns, 43(2): 326-36, 2017. [DOI] [PubMed] [Google Scholar]
- 3.Rosenberg L, Krieger Y, Bogdanov-Berezovski A, Silberstein E, et al. : A novel rapid and selective enzymatic debridement agent for burn wound management: a multi-center RCT. Burns, 40(3): 466-74, 2014. [DOI] [PubMed] [Google Scholar]
- 4.Rosenberg L, Shoham Y, Krieger Y, Rubin G, et al. : Minimally invasive burn care: a review of seven clinical studies of rapid and selective debridement using a bromelain-based debriding enzyme (Nexobrid®). Ann Burns Fire Disasters, 28(4): 264-74, 2015. [PMC free article] [PubMed] [Google Scholar]
- 5.Schulz A, Fuchs P, Rothermundt I, Hoffmann A, et al. : Enzymatic debridement of deeply burned faces: healing and early scarring based on tissue preservation compared to traditional surgical debridement. Burns, 43(6): 1233-1243, 2017. [DOI] [PubMed] [Google Scholar]
- 6.Giudice G, Filoni A, Maggio G, Bonamonte D, Vestita M: Cost analysis of a novel enzymatic debriding agent for management of burn wounds. Biomed Res Int [Internet], 2017. Feb 15 [cited 2021 Oct 8]. Available from: https://www.hindawi.com/journals/bmri/2017/9567498/ [DOI] [PMC free article] [PubMed]
- 7.Cordts T, Horter J, Vogelpohl J, Kremer T, et al. : Enzymatic debridement for the treatment of severely burned upper extremities – early single center experiences [Internet]. BMC Dermatology, 16, 2016. Available from: 10.1186/s12895-016-0045-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Hirche C, Citterio A, Hoeksema H, Koller J, et al. : Eschar removal by bromelain based enzymatic debridement (Nexobrid) in burns: a European consensus. Burns, 43(8): 1640-53, 2017. [DOI] [PubMed] [Google Scholar]
- 9.Esfahlan A, Lotfi M, Zamanzadeh V, Babapuor J: Burn pain and patients’ responses. Burns, 36(7): 1129-1133, 2010. [DOI] [PubMed] [Google Scholar]
- 10.Faucher L, Furukawa K: Practice guidelines for the management of pain. J Burn Care Res, 27(5): 659-68, 2006. [DOI] [PubMed] [Google Scholar]
- 11.Herbert C: Pain: Clinical manual (2nd edn) by M. McCaffrey & C. Pasero. 1999. C. V. Mosby, St Louis. ISBN 0 8051 5609 X. Pp. 796. £21.95. J Clin Nurs, 9(4): 650–650, 2000. [Google Scholar]
- 12.Richardson P, Mustard L: The management of pain in the burns unit. Burns, 35(7): 921-36, 2009. [DOI] [PubMed] [Google Scholar]
- 13.Edwards RR, Magyar-Russell G, Thombs B, Smith MT, et al. : Acute pain at discharge from hospitalization is a prospective predictor of long-term suicidal ideation after burn injury. Arch Phys Med Rehabil, 88(12 Suppl 2): S36-42, 2007. [DOI] [PubMed] [Google Scholar]
- 14.Edwards RR, Smith MT, Klick B, Magyar-Russell G, et al. : Symptoms of depression and anxiety as unique predictors of pain-related outcomes following burn injury. Ann Behav Med, 34(3): 313-22, 2007. [DOI] [PubMed] [Google Scholar]
- 15.Ranno R, Vestita M, Maggio G, Verrienti P, et al. : Italian recommendations on enzymatic debridement in burn surgery. Burns, 47(2): 408-416, 2021. [DOI] [PubMed] [Google Scholar]
- 16.Hirche C, Kreken Almeland S, Dheansa B, Fuchs P, et al. : Eschar removal by bromelain based enzymatic debridement (Nexobrid®) in burns: European consensus guidelines update. Burns, 46(4): 782-796, 2020. [DOI] [PubMed] [Google Scholar]
- 17.James DL, Jowza M: Principles of burn pain management. Clin Plast Surg, 44(4): 737-47, 2017. [DOI] [PubMed] [Google Scholar]
- 18.Wasiak J, Spinks A, Costello V, Ferraro F, et al. : Adjuvant use of intravenous lidocaine for procedural burn pain relief: a randomized double-blind, placebo-controlled, cross-over trial. Burns, 37(6): 951-7, 2011. [DOI] [PubMed] [Google Scholar]
- 19.Loo YL, Goh BKL, Jeffery S: An overview of the use of bromelain-based enzymatic debridement (Nexobrid®) in deep partial and full thickness burns: appraising the evidence. J Burn Care Res, 39(6): 932-8, 2018. [DOI] [PubMed] [Google Scholar]
- 20.Dubin AE, Patapoutian A: Nociceptors: the sensors of the pain pathway. J Clin Invest, 120(11): 3760-72, 2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Shank ES, Martyn JA, Donelan MB, Perrone A, et al. : Ultrasoundguided regional anesthesia for pediatric burn reconstructive surgery: a prospective study. J Burn Care Res, 37(3): e213-7, 2016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Sheckter CC, Stewart BT, Barnes C, Walters A, et al. : Techniques and strategies for regional anesthesia in acute burn care - a narrative review. Burns Trauma, 17(9): tkab015, 2021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Tarsia V, Singer AJ, Cassara GA, Hein MT: Percutaneous regional compared with local anaesthesia for facial lacerations: a randomised controlled trial. Emerg Med J, 22(1): 37-40, 2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Nordin P, Zetterström H, Carlsson P, Nilsson E: Cost-effectiveness analysis of local, regional and general anaesthesia for inguinal hernia repair using data from a randomized clinical trial. Br J Surg, 94(4): 500-5, 2007. [DOI] [PubMed] [Google Scholar]
- 25.Abrão J, Antunes M, Vicente Garcia L: Local anesthetics infiltration and wound healing process. In: Whizar-Lugo VM, Hernández-Cortez E. (Eds): “Topics in Local Anesthetics”, IntechOpen, 2020. [Google Scholar]
- 26.Kesici S, Demirci M, Kesici U: Antibacterial effects of lidocaine and adrenaline. Int Wound J, 16(5): 1190-4, 2019. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Cassuto J, Sinclair R, Bonderovic M: Anti-inflammatory properties of local anesthetics and their present and potential clinical implications. Acta Anaesthesiol Scand, 50(3): 265-82, 2006. [DOI] [PubMed] [Google Scholar]
- 28.Wibbenmeyer L, Danks R, Faucher L, Amelon M, et al. : Prospective analysis of nosocomial infection rates, antibiotic use, and patterns of resistance in a burn population. J Burn Care Res, 27(2): 152-60, 2006. [DOI] [PubMed] [Google Scholar]
- 29.Capdevila X, Bringuier S, Borgeat A: Infectious risk of continuous peripheral nerve blocks. Anesthesiology, 110(1): 182-8, 2009. [DOI] [PubMed] [Google Scholar]
- 30.Grewal S, Hocking G, Wildsmith JAW: Epidural abscesses. Br J Anaesth, 96(3): 292-302, 2006. [DOI] [PubMed] [Google Scholar]
- 31.Richard R, Santos-Lozada AR: Burn patient acuity demographics, scar contractures, and rehabilitation treatment time related to patient outcomes: The ACT Study. J Burn Care Res, 38(4): 230-42, 2017. [DOI] [PubMed] [Google Scholar]
- 32.Dewey WS, Cunningham KB, Shingleton SK, Pruskowski KA, et al. : Safety of early postoperative range of motion in burn patients with newly placed hand autografts: a pilot study. J Burn Care Res, 41(4): 809-13, 2020. [DOI] [PubMed] [Google Scholar]
- 33.Liu SS, Ware PD, Allen HW, Neal JM, Pollock JE: Dose-response characteristics of spinal bupivacaine in volunteers. Clinical implications for ambulatory anesthesia. Anesthesiology, 85(4): 729-36, 1996. [DOI] [PubMed] [Google Scholar]
